Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice

European Neuropsychopharmacology

Volumn 21, Issue 9, 2011, Pages 705-714

  Dhir, Ashish ^a   Malik, Sneh ^b   Kessar, S V ^b   Singh, K N ^b   Kulkarni, S K ^a  

^a PANJAB UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

1 (7 Methoxy 2 methyl 1,2,3,4 tetrahydro isoquinolin 4 yl) cyclohexanol; ; Animal models of depression; ; Neurotransmitters; Trace amine receptors;

Indexed keywords

1 (7 METHOXY 2 METHYL 1,2,3,4 TETRAHYDRO ISOQUINOLIN 4 YL)CYCLOHEXANOL; ANTIDEPRESSANT AGENT; BARBITURIC ACID DERIVATIVE; DOPAMINE; FLUOXETINE; IMIPRAMINE; NEUROTRANSMITTER; NORADRENALIN; PHENETHYLAMINE; RESERPINE; SEROTONIN; UNCLASSIFIED DRUG; VENLAFAXINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; DRUG DOSE; DRUG STRUCTURE; DRUG SYNTHESIS; FORCED SWIMMING TEST; HYPNOSIS; IMMOBILIZATION; LOCOMOTOR SYSTEM TUMOR; MAJOR DEPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEDATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; BIOGENIC AMINES; BRAIN; CYCLOHEXANOLS; DEPRESSION; DISEASE MODELS, ANIMAL; HINDLIMB SUSPENSION; HYPNOTICS AND SEDATIVES; ISOQUINOLINES; MALE; MICE; MOTOR ACTIVITY; NEUROTRANSMITTER AGENTS; PENTOBARBITAL; RESERPINE; SLEEP; SWIMMING;

EID: 80052368092     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2010.12.003     Document Type: Article

References (24)

1. Beyer C.E., Boikess S., Luo B., Dawson L.A. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study. J. Psychopharmacology 2002, 16:297-304.
2. Branchek T.A., Blackburn T.P. Trace amine receptors as targets for novel therapeutics: legend, myth and fact. Curr. Opin. Pharmacol. 2003, 3:90-97.
3. Cooper B.R., Hester T.J., Maxwell R.A. Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo. J. Pharmacol. Exp. Ther. Oct 1980, 215(1):127-134.
4. Davis B.A., Boulton A.A. The trace amines and their acidic metabolites in depression-an overview. Prog. Neuropsychopharmacol. Biol. Psychiatry 1994, 18:17-45.
5. Dhir A., Kulkarni S.K. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist. Brain Res. Bull. 2007, 74:58-65.
6. Dhir A., Kulkarni S.K. Possible involvement of sigma-1 receptors in the anti-immobility action of bupropion, a dopamine reuptake inhibitor. Fundam. Clin. Pharmacol. 2008, 22:387-394.
7. Dhir A., Kulkarni S.K. Involvement of sigma (sigma1) receptors in modulating the anti-depressant effect of neurosteroids (dehydroepiandrosterone or pregnenolone) in mouse tail-suspension test. J. Psychopharmacol. 2008, 22:691-696.
8. Dhir A., Naidu P.S., Kulkarni S.K. Protective effect of cyclooxygenase-2 COX-2 inhibitors but not non-selective cyclooxygenase COX-inhibitors on ethanol withdrawal-induced behavioural changes. Addict. Biol. 2005, 10:329-335.
9. Gelenberg A.J. A review of the current guidelines for depression treatment. J. Clin. Psychiatry 2010, 71:e15.
10. Ide S., Sora I., Ikeda K., Minami M., Uhl G.R., Ishihara K. Reduced emotional and corticosterone responses to stress in mu-opioid receptor knockout mice. Neuropharmacology 2010, 58:241-247.
11. Kulkarni S.K. Experiments on intact preparation. Handbook of Experimental Pharmacology 1999, 123-124. Vallabh Prakashan, Delhi. S.K. Kulkarni (Ed.).
12. Kulkarni S.K., Dhir A. Effect of various classes of antidepressants in behavioral paradigms of despair. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:1248-1254.
13. Kulkarni S.K., Dhir A. Current investigational drugs for major depression. Expert Opin. Investig. Drugs 2009, 18:767-788.
14. Kulkarni S.K., Mehta A.K. Purine nucleoside-mediated immobility in mice, reversal by antidepressants. Psychopharmacol. Berl 1985, 85:460-463.
15. Parale M.P., Kulkarni S.K. Clonidine-induced behavioural despair in mice: reversal by antidepressants. Psychopharmacology 1986, 89:171-174.
16. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
17. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 1978, 47:379-391.
18. Premont R.T., Gainetdinov R.R., Caron M.G. Following the trace of elusive amines. Proc. Natl Acad. Sci. USA 2001, 98:9474-9475.
19. Reddy D.S., Kaur G., Kulkarni S.K. Sigma (sigma1) receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test. NeuroReport 1998, 9:3069-3073.
20. Shaji A.V., Kulkarni S.K. Central nervous system depressant activities of melatonin in rats and mice. Indian J. Exp. Biol. 1988, 36:257-263.
21. Sharma A., Kulkarni S.K. Dopamine receptor mediated antidepressant action of B-HT 920 in mice. Indian J. Exp. Biol. 1994, 32:172-175.
22. Sills T.L., Greenshaw A.J., Baker G.B., Fletcher P.J. Acute fluoxetine treatment potentiates amphetamine hyperactivity and amphetamine-induced nucleus accumbens dopamine release: possible pharmacokinetic interaction. Psychopharmacol. Berl 1999, 141:421-427.
23. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985, 85:367-370.
24. Zomkowski A.D., Engel D., Gabilan N.H., Rodrigues A.L. Involvement of NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming test. Eur. Neuropsychopharmacol. 2010, 20:793-801.